Encycle Therapeutics, a Toronto-based drug discovery company, announced a research collaboration with Pfizer. Encycle and Pfizer will partner to optimize certain nacellins, which were previously identified by Pfizer during a screening of Encycle’s proprietary nacellin library, that act on an undisclosed therapeutic target.
Read the full press release here: https://globenewswire.com/news-release/2017/11/01/1172159/0/en/Encycle-Therapeutics-announces-discovery-collaboration-with-Pfizer-Inc.html